An Exclusive Interview with Edith Perez, MD
Deputy Director, Mayo Clinic Cancer Center
Group Vice-Chair, Alliance for Clinical Trials in Oncology
Serene M. and Frances C. Durling
Professor of Medicine, College of Medicine
Director of the Breast Program
Mayo Clinic
Jacksonville, Florida

Dr. Edith Perez, an internationally renowned expert in the treatment of breast cancer, offers her comments on the 2012 Annual Meeting of the American Society of Clinical Oncology and the standard of care for breast malignancies.

Dr. Perez discusses her ASCO 2012 abstract entitled: “Effect of PTEN protein expression on benefit to adjuvant trastuzumab in early-stage HER2+ breast cancer in NCCTG adjuvant trial N9831“: Play
Dr. Perez discusses the translation of the PTEN adjuvant data into the development of future clinical trials: Play
Dr. Perez discusses her presentation of the VELVET trial: a phase 2 trial in progress to assess combination therapy, including pertuzumab, trastuzumab, and vinorelbine, in HER2-positive metastatic breast cancer: Play

Continue Reading